Resorbable structure for treating and healing of tissue defects
OwnerDouglas G. Evans, Jeffrey C. Kelly +1inventors
InventorsDouglas G. Evans, Jeffrey C. Kelly, Todd M. DeWitt
Life of this patent
Estimating the term…
Loading patent…
OwnerDouglas G. Evans, Jeffrey C. Kelly +1inventors
InventorsDouglas G. Evans, Jeffrey C. Kelly, Todd M. DeWitt
Estimating the term…
Devices and processes (e.g., improved Plasticized Melt Flow processes (PMF) or improved Phase Separation Polymer Concentration (PSPC), etc.) used to make resorbable and non-resorbable structures for treating and/or healing of tissue defects are disclosed. Among the advantages of using these improved processes are the preservation of molecular weight and the broadening of the processing conditions for temperature sensitive polymers and therapies (e.g. polylactide, polyglycolide, polycaprolactone or Cisplatin, etc.). This reduction in processing temperature, pressure and time can help to preserve the molecular weight and/or integrity of the final product or any additive incorporated therein. Additionally, pore size and shape tailoring can increase the osteoconductive nature of the device.
A porous polymeric device manufactured with a plasticized melt flow process utilizing a matrix polymer and a fluid, said device being implantable to treat tissue or defects therein;
A porous polymeric device manufactured with a plasticized melt flow process, wherein the chamber material consists essentially of a matrix polymer and a fluid, said device being implantable to treat tissue or defects therein;
A porous polymeric device manufactured with a plasticized melt flow process, wherein the chamber material consists essentially of a matrix polymer and a fluid, said device being implantable to treat tissue or defects therein;
Dependencies are inferred from the claim text.